Home › GenVec Inc (GNVC) Rating Increased to Buy at Zacks Investment Research
 

Keywords :   


GenVec Inc (GNVC) Rating Increased to Buy at Zacks Investment Research

2016-02-06 19:17:43| Biotech - Topix.net

The firm currently has a $0.50 price objective on the biopharmaceutical company's stock. Zacks Investment Research 's price target indicates a potential upside of 2.02% from the company's previous close.

Tags: buy research rating increased

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »